Mobia Medical, Inc. (MOBI)
Nasdaq · Surgical & Medical Instruments & Apparatus · Manufacturing · CIK 1489993 · fiscal year ends in Dec
Closing price $10.54 on 30 Oct 2026; 52-week range $8.08 to $14.63.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Market value
- $350.8M
- Cash
- $177.1M
- Debt
- $7.3M
- Debt to equity
- 0.04
- Shares outstanding
- 33.3M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $13.5M | -$21.0M | -$1.10 |
| Q1 FY2026 | 31 Mar 2026 | $12.1M | -$17.7M | -$0.92 |
| Q2 FY2025 | 30 Jun 2025 | $6.7M | -$10.5M | -$12.44 |
| Q1 FY2025 | 31 Mar 2025 | $5.7M | -$10.7M | -$0.62 |
Company events
The newest 8-K filings of 6 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 16 Oct 2026 | 8-K/A | Leadership change | 5.02 |
| 16 Oct 2026 | 8-K/A | Leadership change | 5.02 |
| 11 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 3 Aug 2026 | 8-K | Leadership change | 5.02 |
| 15 Jul 2026 | 8-K | Leadership change | 5.02 |
| 11 May 2026 | 8-K | Bylaws or fiscal year change | 5.03, 9.01 |
Every filing
The newest filings with the SEC of 31 held.
| Filed | Form | Period |
|---|---|---|
| 16 Oct 2026 | 8-K/A | 30 Jul 2026 |
| 16 Oct 2026 | 8-K/A | 14 Jul 2026 |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 11 Aug 2026 | 8-K | 11 Aug 2026 |
| 3 Aug 2026 | 8-K | 30 Jul 2026 |
| 15 Jul 2026 | 8-K | 14 Jul 2026 |
| 4 Jun 2026 | 10-Q | 31 Mar 2026 |
| 11 May 2026 | 8-K | 11 May 2026 |
| 8 May 2026 | S-8 | – |
| 7 May 2026 | EFFECT | – |
| 7 May 2026 | CERT | – |
| 7 May 2026 | 8-A12B | – |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 11 Sep 2026 | Leavitt Chase C., SEE REMARKS | Purchase | 2,000 | $10.30 | $20.6K | 5,000 | 15 Sep 2026 |
| 18 Aug 2026 | Tansey Casey M, Director | Purchase | 16,441 | $12.07 | $198.5K | 318,332 | 20 Aug 2026 |
| 17 Aug 2026 | Tansey Casey M, Director | Purchase | 17,166 | $11.85 | $203.4K | 301,891 | 17 Aug 2026 |
| 14 Aug 2026 | Tansey Casey M, Director | Purchase | 15,721 | $11.65 | $183.2K | 284,625 | 17 Aug 2026 |
| 14 Aug 2026 | Tansey Casey M, Director | Purchase | 100 | $12.53 | $1.3K | 284,725 | 17 Aug 2026 |
| 13 Aug 2026 | Tansey Casey M, Director | Purchase | 35,572 | $11.51 | $409.3K | 268,904 | 17 Aug 2026 |
| 11 May 2026 | Green Park & Golf Ventures - Houston, Llc, 10% owner | Purchase | 60,537 | $15.00 | $908.1K | 60,537 | 29 Jun 2026 |
| 11 May 2026 | Green Park & Golf Ventures Ii, Llc, 10% owner | Purchase | 33,333 | $15.00 | $500.0K | 80,157 | 29 Jun 2026 |
| 11 May 2026 | Green Park & Golf Ventures Ii, Llc, 10% owner | Sale outside a trading plan | 6,731 | – | $0 | 43,799 | 29 Jun 2026 |
| 11 May 2026 | Green Park & Golf Ventures Ii, Llc, 10% owner | Purchase | 81,000 | $15.00 | $1.2M | 81,000 | 29 Jun 2026 |
| 9 Jun 2026 | Curnes Nelson Bunker, Chief Financial Officer | Purchase | 5,000 | $12.79 | $64.0K | 366,997 | 11 Jun 2026 |
| 11 May 2026 | Osage University Gp Iii, Llc, 10% owner | Purchase | 266,666 | $15.00 | $4.0M | 2,006,716 | 12 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 14 Aug 2026 | GPG BFH, LLC | 13G | 11.1% | 3.7M |
| 13 Aug 2026 | U.S. Venture Partners XII, L.P. | 13G | 11.6% | 3.9M |
| 18 May 2026 | Synapse Investment, LP | 13G | 6% | 2.0M |
| 15 May 2026 | Osage University Partners III, LP | 13D | 10.3% | 3.4M |
| 15 May 2026 | Gilde Healthcare Holding B.V. | 13G | 6.3% | 2.1M |
| 13 May 2026 | Longitude Capital Partners V, LLC | 13D | 9.8% | 3.3M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 850.2K | -21.55% | 6.46 |
| 30 Sep 2026 | 1.1M | +130.74% | 2.84 |
| 15 Sep 2026 | 469.7K | +31.19% | 2.24 |
| 31 Aug 2026 | 358.0K | -19.3% | 2.63 |
| 14 Aug 2026 | 443.7K | -7.5% | 3.99 |
| 31 Jul 2026 | 479.6K | +13.55% | 6.18 |
| 15 Jul 2026 | 422.4K | -65.77% | 3.43 |
| 30 Jun 2026 | 1.2M | +49.06% | 5.41 |
Funds that hold it
From each fund's latest Form 13F.
44 funds held it at 30 Jun 2026: 44 added and 0 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| SR One Capital Management, LP | 1,986,072 | $26.6M | +1,986,072 |
| Farallon Capital Management, L.l.c. | 1,128,557 | $15.1M | +1,128,557 |
| Avidity Partners Management LP | 798,282 | $10.7M | +798,282 |
| Deerfield Management Company, L.P. | 670,752 | $9.0M | +670,752 |
| Aberdeen Group plc | 584,570 | $7.8M | +584,570 |
| Perceptive Advisors LLC | 523,654 | $7.0M | +523,654 |
| Vanguard Capital Management LLC | 444,355 | $6.0M | +444,355 |
| Rock Springs Capital Management LP | 418,200 | $5.6M | +418,200 |
| Balyasny Asset Management L.P. | 387,500 | $5.2M | +387,500 |
| Integral Health Asset Management, LLC | 250,000 | $3.4M | +250,000 |
Peers
Companies in the same industry.
- Stryker Corp. (SYK): revenue $26.3B, market value $110.9B
- 3M Co. (MMM): revenue $25.2B, market value $90.1B
- Boston Scientific Corp. (BSX): revenue $21.0B, market value $60.8B
- Becton Dickinson & Co. (BDX): revenue $20.8B, market value $53.9B
- Medline Inc. (MDLN): revenue –, market value $42.2B
- Resmed Inc. (RMD): revenue $5.7B, market value $32.3B
- Dexcom Inc. (DXCM): revenue $5.1B, market value $30.7B
- West Pharmaceutical Services Inc. (WST): revenue $3.4B, market value $28.8B
- Glaukos Corp. (GKOS): revenue $690.3M, market value $14.1B
- Solventum Corp. (SOLV): revenue $8.3B, market value $13.8B